/ Ajanta Pharma Issues One Procedural Related 483, Stock Reacts ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Thursday, 9 February 2017

Ajanta Pharma has issued one procedural related 483 with reference to to the company’s Paithan facility. Paithan facility was inspected by US FDA. The company is expected to respond to the observation made by the US FDA.

The stock of the company while filing this report is trading with gains of nearly 3%. In the last one year, the stock of the company has surged by 38.14% and is trading with the P/E of 31.94.

Motilal Oswal Mutual Fund is the top fund house which has invested in the stock of the company and has made an investment of 1.5% of the equity capital. Ajanta Pharma Ltd is currently trading at Rs 1807.1, up by Rs 48 or 2.73% from its previous closing of Rs 1759.1 on the BSE.

The scrip opened at Rs 1768.2 and has touched a high and low of Rs 1833.9 and Rs 1740 respectively. So far 689132(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs 15480.96 crore.

The BSE group 'A' stock of face value Rs 2 has touched a 52 week high of Rs 2150 on 28-Oct-2016 and a 52 week low of Rs 1203.6 on 17-Feb-2016. Last one week high and low of the scrip stood at Rs 1775 and Rs 1690.45 respectively.

The promoters holding in the company stood at 73.78 % while Institutions and Non-Institutions held 12.43 % and 13.79 % respectively. The stock is currently trading above its 100 DMA.

For Quick Trial – 8962000225 ✔
or mail us here: info@ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007
Give a Missed Call for Free Trial - 09699997717